EXTRA-78760 - USA (Rockville, Maryland) - Ultra-Rare Gene-Based Therapy Network Service - Deadline November 2,2026

(1) Vendor needs to provide Ultra–rare Gene–based Therapy (URGenT) network service to the government authority located in Rockville, MD. • Provide drug discovery and development Senior Advisor 2 Subject Matter Expert support services as members of URGenT.• Advancing gene–based and transcript directed therapy–related trials.• Collaborative research among multiple institutions or teams. • Biologic drug discovery for nervous system conditions.• Advise regarding suitability and relevance of proposed URGenT program product development milestones and evaluate project progress relative to established milestones.• Analyze potential opportunities and concerns for future URGenT program projects under consideration.• Recommend potential solutions and assist in implementation of selected strategies to resolve programmatic challenges related to gene–based and transcript directed therapy for drug discovery and development as they arise.(2) The contract period will be for one year. (3) This bid is set aside for total small business.